From: Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis
Organ | Day 14 | Day 90 | ||||||
---|---|---|---|---|---|---|---|---|
EC2319 (n = 8) | Saline (n = 8) | P value | Treatment effect | EC2319 (n = 10) | Saline (n = 10) | P value | Treatment effect | |
Adrenal glands | 9.55 ± 4.32 | 17.55 ± 2.91 | < 0.001 | ↓ | 3.02 ± 1.65 | 9.89 ± 6.92 | 0.01 | ↓ |
Brain | 0.73 ± 0.16 | 0.80 ± 0.24 | 0.51 | ↓ | 0.48 ± 0.39 | 0.90 ± 0.58 | 0.08 | ↓ |
Heart | 4.94 ± 2.68 | 13.72 ± 5.17 | 0.002 | ↓ | 1.70 ± 0.81 | 4.50 ± 3.35 | 0.03 | ↓ |
Kidneys | 483.01 ± 135.74 | 480.04 ± 108.58 | 0.96 | ↑ | 168.51 ± 119.09 | 371.09 ± 188.35 | 0.01 | ↓ |
Liver | 12.03 ± 5.98 | 34.06 ± 10.74 | < 0.001 | ↓ | 4.49 ± 3.6 | 11.82 ± 8.8 | 0.03 | ↓ |
Lungs | 5.57 ± 2.54 | 12.44 ± 3.99 | 0.0015 | ↓ | 2.14 ± 0.99 | 5.99 ± 4.21 | 0.02 | ↓ |
Lymph node | 38.28 ± 13.38 | 64.84 ± 6.42 | < 0.001 | ↓ | 14.83 ± 9.51 | 46.01 ± 30.30 | 0.01 | ↓ |
Muscle | 2.82 ± 1.16 | 6.85 ± 1.97 | < 0.001 | ↓ | 1.04 ± 0.58 | 3.47 ± 2.54 | 0.02 | ↓ |
Pancreas | 10.19 ± 3.83 | 27.53 ± 7.49 | < 0.001 | ↓ | 3.90 ± 2.24 | 11.94 ± 8.63 | 0.02 | ↓ |
Plasma | 1.85 ± 0.78 | 2.17 ± 1.58 | 0.62 | ↓ | 1.43 ± 0.45 | 1.71 ± 0.11 | 0.08 | ↓ |
Salivary gland | ND | ND | ND | ND | 11.98 ± 9.84 | 39.39 ± 24.62 | 0.01 | ↓ |
Skin | 10.53 ± 8.71 | 10.30 ± 4.02 | 0.95 | ↑ | 2.47 ± 1.65 | 7.44 ± 4.34 | 0.01 | ↓ |
Skull | 3.23 ± 1.58 | 6.32 ± 1.63 | 0.002 | ↓ | 1.19 ± 0.98 | 2.99 ± 2.28 | 0.04 | ↓ |
Small intestine | 16.99 ± 7.46 | 37.82 ± 9.98 | < 0.001 | ↓ | 5.71 ± 3.10 | 18.63 ± 14.02 | 0.02 | ↓ |
Spleen | 36.02 ± 17.56 | 107.40 ± 24.24 | < 0.001 | ↓ | 9.68 ± 3.79 | 47.82 ± 39.15 | 0.01 | ↓ |
Urine | 102.82 ± 67.31 | 167.88 ± 76.67 | 0.09 | ↓ | 132.55 ± 92.40 | 218.37 ± 168.11 | 0.18 | ↓ |
White adipose | 1.93 ± 0.81 | 5.07 ± 1.32 | < 0.001 | ↓ | 0.61 ± 0.36 | 1.53 ± 0.88 | 0.01 | ↓ |